The plasma protein binding of drugs has been shown to have significant effects on the
quantitative relationship between clinical pharmacokinetics and pharmacodynamics. In many …

A novel liquid chromatography/tandem mass spectrometry (LC/MS/MS)‐based depletion
method for measuring compound partitioning between human plasma and red blood cells (RBC…

This article describes the discovery of a series of potent inhibitors of Polo-like kinase 1 (PLK1).
Optimization of this benzolactam-derived chemical series produced an orally bioavailable …

Purpose: Patients with neurofibromatosis type 1 (NF1) develop malignant peripheral nerve
sheath tumors (MPNST), which are often inoperable and do not respond well to current …

Aim The aim of the present study was to characterize the pharmacokinetics of the oral
proteasome inhibitor, ixazomib, in patients with solid tumours and moderate or severe hepatic …

Characterizing in vivo cellular kinetics and biodistribution of chimeric antigen receptor T (CAR-T)
cells is critical for toxicity assessment, nonclinical and clinical efficacy studies. To date, …

In the ongoing quest for ever more rapid techniques to quantify small organic molecules, we
have evaluated a chemiluminescent nitrogen detector (CLND) as a universal quantitation …

The microdosing strategy allows for early assessment of human pharmacokinetics of new
chemical entities using more limited safety assessment requirements than those requisite for a …

Purpose: Pediatric glioblastoma multiforme (pGBM) is a highly aggressive tumor in need of
novel therapies. Our objective was to demonstrate the therapeutic efficacy of MLN8237 (…

Plasma stability assessment under physiological temperature is an essential step for
developing and optimizing antibody drug conjugate (ADC) molecules, especially those with …